Methods of using G-CSF analog compositions
AssigneeMassachusetts Institute of Technology
InventorsCasim A. Sarkar, Douglas A. Lauffenburger, Bruce Tidor
Life of this patent
Estimating the term…
Abstract
The present invention relates to granulocyte colony stimulating factor (“G-CSF”) analog polypeptide compositions, related nucleic acids, expression constructs, host cells, and processes for recombinant production of the present G-CSF analogs. The concept detailed herein involves novel mutants of G-CSF, using single substitutions to amino acids, which were rationally chosen to affect the cellular trafficking of G-CSF and/or G-CSFR. In addition, pharmaceutical compositions, and methods of use are provided.
Claims4
A method of treating a condition which is responsive to treatment with G-CSF comprised of administering an effective amount of a composition comprising a human Granulocyte Colony Stimulating Factor (G-CSF) analog polypeptide which comprises an amino acid substitution in the sequence of SEQ ID NO:
- 2 selected from the group consisting of:
- a) a substitution of aspartic acid with histidine at position number 109, [His109]G-CSF;
- b) a substitution of aspartic acid with histidine at position number 112, [His112]G-CSF;
- c) a substitution of glutamine with histidine at position number 119, [His119]G-CSF;
- d) any of the said analogs of subparts (a-c) optionally including an N-terminal methionyl residue;
- and
- e) any of(a)-(d) derivatized with one or more water soluble polymers to a patient in need thereof.
Dependencies are inferred from the claim text.